[Improvement in treatment of patients with gonorrheal epididymo-orchitis].
Examinations of 46 patients with gonorrheal orchiepididymitis have revealed reduced IgA, IgG and IgM levels, a rise of circulating immune complexes level, and depressed lysozyme activity. Addition of proteolytic enzymes to combined therapy has improved the treatment efficacy and normalized the humoral immunity and nonspecific defense parameters.
Glozman
V N
VN
Guseva
L N
LN
D000293:Adolescent; D000328:Adult; D000917:Antibody Formation / Q000187:drug effects / Q000276:immunology; D000936:Antigen-Antibody Complex / Q000032:analysis; D004359:Drug Therapy, Combination; D004823:Epididymitis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D006069:Gonorrhea / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects / Q000276:immunology; D007136:Immunoglobulins / Q000032:analysis; D008297:Male; D009920:Orchitis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology
D000936:Antigen-Antibody Complex; D007136:Immunoglobulins
Sovershenstvovanie terapii bol'nykh gonoreĭnym épididimoorkhitom.